RE:RE:March 29 2018Startup? After all the years Prometic has been in business they
should not resemble a startup. They should have 10 times their
current sales and be breaking even by now. Not sure how one
can loose all of ones money in 1 name when you own 50 names.
The big pharmaceutical companies have sales earnings and pay
dividends and also had a good week. This puppy is more of a stumbling
also ran at the moment. Get that April FDA approval and it moves
closer to where we were led to believe it was 12 months ago.
Stocks in the penalty box trade at a discount and the lack of cash allowed
the shorts to have their way with us and nothing but a deal or a FDA
yes is going to change that. We aren’t Captain Kirk.